Workflow
NRG(NRG)
icon
Search documents
NRG (NRG) Upgraded to Strong Buy: What Does It Mean for the Stock?
ZACKS· 2025-01-28 18:00
NRG Energy (NRG) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.The power of a changing ...
NRG Energy (NRG) Rises As Market Takes a Dip: Key Facts
ZACKS· 2025-01-25 00:06
NRG Energy (NRG) closed the latest trading day at $112.37, indicating a +1.66% change from the previous session's end. The stock exceeded the S&P 500, which registered a loss of 0.29% for the day. At the same time, the Dow lost 0.32%, and the tech-heavy Nasdaq lost 0.5%.The power company's stock has climbed by 19.07% in the past month, exceeding the Utilities sector's loss of 1.8% and the S&P 500's gain of 2.52%.Investors will be eagerly watching for the performance of NRG Energy in its upcoming earnings di ...
NRG vs. VST: Which Stock Is the Better Value Option?
ZACKS· 2025-01-22 17:46
Investors looking for stocks in the Utility - Electric Power sector might want to consider either NRG Energy (NRG) or Vistra Corp. (VST) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look.There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The proven Zacks Rank puts an emphasis on ...
Here's Why NRG Energy (NRG) is a Strong Value Stock
ZACKS· 2025-01-20 15:45
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.It also includes access to the Zacks Style Scores. ...
NRG Energy: Soaring Consumer Demand Sees Its Upside Potential
Seeking Alpha· 2025-01-14 15:03
First Principles Partners is an equity research analyst specializing in technology, innovation, and sustainability investment. My unique approach, "First Principles," involves breaking down complex problems to their most basic elements in terms of financial and technology, enabling me to uncover overlooked investment opportunities.With a strong background in investment, private equity and venture capital, I have a proven track record of delivering strong returns for readers. Articles on Seeking Alpha focus ...
Here's Why NRG Energy (NRG) is a Strong Momentum Stock
ZACKS· 2025-01-07 16:06
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.Zacks Premium also includes the Zacks Style Scores. What are the Zacks Style Scores? Developed alongsid ...
Direct Energy Invests in Hope and Healing through $60,000 Donation to Two Alberta Hospitals
Newsfilter· 2024-12-19 16:54
CALGARY, Alberta, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Direct Energy is donating $30,000 each to the Alberta Children's Hospital Foundation and the Stollery Children's Hospital Foundation, directing energy toward what matters — Alberta customers, their families, and the communities it serves. These donations are just one example of this ongoing support. "We're honored to support these hospitals by making an investment in hope, healing and the health of our communities," said Tanis Kozak, vice president, Direct ...
NRG Energy: Electrifying Growth, But Overvalued
Seeking Alpha· 2024-12-18 21:44
NRG Energy (NYSE: NRG ) recently announced its Q3 results and its performance wasn’t as good as it was supposed to be. It missed EPS estimates and reported a significant net loss. NRG is one of the biggest names inI am a financial writer with a degree in Finance. In my five-year career, I have worked with two financial companies. I keep a close eye on Energy, Banking, and Tech stocks. My main focus is fundamental analysis and looking at the long-term position of a stock instead of short-term analysis. The m ...
Merus Announces FDA Approval of BIZENGRI® (zenocutuzumab-zbco) for NRG1+ Pancreatic Adenocarcinoma and NRG1+ Non–Small Cell Lung Cancer (NSCLC) Based on Safety and Efficacy Data From the eNRGy Study
GlobeNewswire News Room· 2024-12-04 21:55
BIZENGRI® is the first and only therapy approved by the FDA specifically for pancreatic adenocarcinoma and NSCLC that harbor NRG1 gene fusions and are advanced unresectable or metastatic1Merus and Partner Therapeutics announced a license agreement for U.S. commercialization UTRECHT, The Netherlands and CAMBRIDGE, Mass., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) [Merus, the Company, we, or our], a clinical-stage oncology company developing innovative, full-length, multispecific antibodies ( ...
Merus and Partner Therapeutics Announce License Agreement for the U.S. Commercialization of Zenocutuzumab in NRG1 Fusion-Positive Cancer
GlobeNewswire News Room· 2024-12-02 13:00
UTRECHT, The Netherlands and CAMBRIDGE, Mass., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®) and Partner Therapeutics, Inc. (PTx), a private, fully-integrated biotechnology company with a focus in hematology and oncology, today announced they have entered into an agreement in which Merus has exclusively licensed to PTx the right to commerc ...